Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan M Curtis

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Seminars in Dialysis|March 5, 2002
How can the cardiac death rate be reduced in dialysis patients?Bryan M Curtis, Patrick S Parfrey
Cardiology Clinics|August 9, 2005
Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and managementBryan M Curtis, Patrick S Parfrey
The Medical Clinics of North America|March 10, 2005
Multiple risk factor intervention in chronic kidney disease: management of cardiac disease in chronic kidney disease patientsBryan M Curtis, Adeera Levin, Patrick S Parfrey
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trialRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2021
Randomized Controlled Trials 1: DesignBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|January 24, 2009
The design of randomized controlled trialsBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|February 20, 2015
Randomized controlled trials 1: DesignBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Methods in Molecular Medicine|July 31, 2003
How to design a clinical trialBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2008
Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapyRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Canadian Journal of Kidney Health and Disease|July 19, 2017
Costs Associated With Intravenous Darbepoetin Versus Epoetin Therapy in Hemodialysis Patients: A Randomized Controlled TrialAndrea L Woodland, Sean W Murphy, Bryan M Curtis, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Seminars in Dialysis|March 5, 2002
How can the cardiac death rate be reduced in dialysis patients?Bryan M Curtis, Patrick S Parfrey
Cardiology Clinics|August 9, 2005
Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and managementBryan M Curtis, Patrick S Parfrey
The Medical Clinics of North America|March 10, 2005
Multiple risk factor intervention in chronic kidney disease: management of cardiac disease in chronic kidney disease patientsBryan M Curtis, Adeera Levin, Patrick S Parfrey
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trialRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2021
Randomized Controlled Trials 1: DesignBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|January 24, 2009
The design of randomized controlled trialsBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Methods in Molecular Biology (Clifton, N.J.)|February 20, 2015
Randomized controlled trials 1: DesignBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Methods in Molecular Medicine|July 31, 2003
How to design a clinical trialBryan M Curtis, Brendan J Barrett, Patrick S Parfrey
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2008
Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapyRobert N Foley, Bryan M Curtis, Patrick S Parfrey
Canadian Journal of Kidney Health and Disease|July 19, 2017
Costs Associated With Intravenous Darbepoetin Versus Epoetin Therapy in Hemodialysis Patients: A Randomized Controlled TrialAndrea L Woodland, Sean W Murphy, Bryan M Curtis, et al.
Pageof 2